top of page
NEWS
News
Search


Blood-stage malaria vaccine candidate BK-SE36 shown to be safe and immunogenic in children
Malaria is a major public health concern, particularly among children in Sub-Saharan Africa.
EVI
Sep 5, 20222 min read


EVI's new publication identifies gaps in outreach information on COVID-19 vaccine trials in Europe
31 August 2022 Together with VACCELERATE partners, European Vaccine Initiative (EVI) just published the main findings of the new freely...
EVI
Aug 31, 20224 min read


VAC2VAC, ‘Vaccine batch to vaccine batch comparison by consistency testing,’ successfully completed
The VAC2VAC project (1 March 2016 - 28 February 2022) was dedicated to developing quality control testing approaches for human and...
EVI
Aug 18, 20223 min read


Asexual blood-stage malaria vaccine candidate PfRipr5: enhanced production in insect cells
05 July 2022 Malaria is a potentially fatal disease caused by parasites transferred to humans through the bites of infected female...
EVI
Jul 5, 20222 min read


New European-African partnership to contribute to the fight against placental malaria
€10 million mobilised by the ADVANCE-VAC4PM consortium to advance the development of a safe, effective, and affordable placental malaria...
EVI
Jun 13, 20223 min read


ShigETEC vaccine candidate against diarrhoeal disease proved to be safe in phase I clinical trial
30 May 2022 Diarrhoea is one of the most common diseases, globally, affecting children under five years of age. Although typically being...
EVI
May 30, 20222 min read


“Vaccines provide everyone a chance at a fulfilling life”
World Immunization Week: 24 – 30 April 2022 For more than two centuries, vaccines have helped keep people healthy—from the very first...
EVI
Apr 25, 20222 min read


World Malaria Day 2022: harness innovation to reduce the malaria disease burden and save lives
Every year on April 25th, the World Malaria Day takes place as an internationally recognised date and an opportunity to commemorate and...
EVI
Apr 25, 20223 min read


EVI joining CEPI-funded programme for development of broadly protective betacoronaviruses vaccines
We are delighted to announce that CEPI, the Coalition for Epidemic Preparedness Innovations has awarded US$200m to advance the...
EVI
Apr 11, 20221 min read


A dose of teamwork against pandemics: TRANSVAC
Collaboration is key to developing vaccines. Merck's article highlights why collaboration in vaccine manufacturing learning is key to...
EVI
Apr 1, 20223 min read


Invest into new, effective TB vaccines to save lives!
Tuberculosis (TB) remains one of the deadliest infectious diseases in the world, killing 1.5 million each year. Around 10 million people...
EVI
Mar 24, 20223 min read


Filling the Global Health Gaps - How could EU R&I and funding contribute?
The latest Deutsche Stiftung Weltbevölkerung (DSW) paper on Filling the Global Health Gaps - How could EU R&I and funding contribute?,...
EVI
Mar 9, 20221 min read


ISIDORe: A new approach to pandemic preparedness research in Europe
24 February, 2022 ISIDORe – “Integrated Services for Infectious Disease Outbreak Research” was officially launched today. The 21M€...
EVI
Feb 24, 20222 min read


PREV_PKDL project strengthens flow cytometry capacity in Africa
11 February 2022 Knowledge sharing and capacity building are key to advance scientific research and innovation. One of the main...
EVI
Feb 11, 20222 min read


World NTD Day, achieving health equity to end the neglect of poverty-related diseases
30 January 2022 This day is designated to raise awareness about Neglected Tropical Diseases (NTDs). The global health and development...
EVI
Jan 30, 20222 min read


PrIMAVeRa kick-off meeting successfully marks the official project launch
1 December, 2021 The PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious...
EVI
Dec 3, 20212 min read


World AIDS Day 2021: End inequalities. End AIDS
1 December 2021 What is world AIDS day? Every year, on December 1st, the World AIDS Day provides an opportunity for the world to come...
EVI
Dec 1, 20212 min read


Open call for expert services and trainings by TRANSVAC2
Research infrastructures are an elegant solution to make science more effective and sustainable. They enable an organized, fair and...
EVI
Nov 25, 20211 min read


Antimicrobial Resistance: the silent pandemic
The annual World Antimicrobial Resistance Awareness Week (WAAW) that runs from the 18th to the 24th of November is an important event...
EVI
Nov 22, 20213 min read


PrIMAVeRa, a new ambitious project to demonstrate how vaccines can combat antimicrobial resistance
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilises more than € 9 million to support PrIMAVeRa, a new public-private...
EVI
Nov 9, 20213 min read


GHIT Fund supports further clinical development of placental malaria vaccine candidates, led by EVI
Placental Malaria (PM) constitutes a major health problem. Globally, it is estimated that at least 25% of pregnant women are infected...
EVI
Nov 4, 20213 min read


Latest results from EVI-led projects, ShigOravax and PREV_PKDL, to be presented at tenth EDCTP forum
The Tenth EDCTP Forum biannually provides an international platform for the presentation and discussion of cutting-edge research...
EVI
Oct 18, 20212 min read


“A long stride down the road” – WHO recommends widespread use of malaria vaccine in African children
In what can be considered a “historic” move forward in the fight against malaria, the World Health Organization (WHO) has recommended...
EVI
Oct 15, 20212 min read


Malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of immune responses
Despite significant progress achieved in the past years, malaria remains a major cause of morbidity and mortality, especially in children...
EVI
Aug 20, 20212 min read
bottom of page